Login / Signup

Screening natural product extracts for potential enzyme inhibitors: protocols, and the standardisation of the usage of blanks in α-amylase, α-glucosidase and lipase assays.

Chintha LankatillakeShiqi LuoMatthew FlavelGeorge Binh LenonHarsharn GillTien HuynhDaniel Anthony Dias
Published in: Plant methods (2021)
The choice of blanks and blank-correction methods contribute to the variability of assay results and the likelihood of underestimating the enzyme inhibitory potential of a test sample. This highlights the importance of standardising the use of blanks and the reporting of blank-correction procedures in published studies in order to ensure the accuracy and reproducibility of results, and avoid overlooked opportunities in drug discovery research due to inadvertent underestimation of enzyme inhibitory potential of test samples resulting from unsuitable blank-correction. Based on our assessments, we recommend method six [RD - (Su + SaB)] as a suitable method for blank-correction of raw data in enzyme assays.
Keyphrases
  • drug discovery
  • high throughput
  • human health
  • systematic review
  • electronic health record
  • artificial intelligence
  • adverse drug
  • case control